Genetic variants may affect breast cancer drug concentrations and patient outcomes

[News]

In a study of 110 women taking the breast cancer drug anastrozole, there were significant differences in patients' blood levels of the drug that corresponded with variations in the ABCB1 gene.

More... (http://www.medicalnewstoday.com/releases/313566.php)